4-Acetyl-Antroquinonol B Improves the Sensitization of Cetuximab on Both Kras Mutant and Wild Type Colorectal Cancer by Modulating the Expression of Ras/Raf/miR-193a-3p Signaling Axis.

{"sci_version": "1.2", "schema": "https://corpus.bntrg.co.uk/sci/1.0/sci.schema.json", "id": "pmid:34299137", "kind": "science-record", "revision": 3, "content_hash": "sha256:2e00c7468f8c5f8fbea02dcf74e3a96effca5212690f1b64d4468334251ce4ab", "created_at": "2026-11-01T15:41:44Z", "updated_at": "2026-11-01T21:25:50Z", "generator": {"name": "corpus-assay-engine", "run_id": "reading-sci-2026-11-01"}, "paper": {"state": "complete", "title": "4-Acetyl-Antroquinonol B Improves the Sensitization of Cetuximab on Both Kras Mutant and Wild Type Colorectal Cancer by Modulating the Expression of Ras/Raf/miR-193a-3p Signaling Axis.", "doi": "10.3390/ijms22147508", "pmid": "34299137", "authors": ["Yi Cheng Chu", "Tung-Yao Tsai", "Vijesh Kumar Yadav", "Li Deng", "Chun-Chih Huang", "Yew-Min Tzeng", "Chi-Tai Yeh", "Ming-Yao Chen"], "journal": "International journal of molecular sciences", "year": 2021, "abstract": "The KRAS mutation is one of the leading driver mutations in colorectal cancer (CRC), and it is usually associated with poor prognosis and drug resistance. Therapies targeting the epidermal growth factor receptor (EFGR) are widely used for end-stage CRC. However, patients with KRAS mutant genes cannot benefit from this therapy because of Ras signaling activation by KRAS mutant genes. Our previous study revealed the anti-proliferative effect of 4-acetyl-antroquinonol B (4-AAQB) on CRC cells, but whether the drug is effective in KRAS-mutant CRC remains unknown. We screened CRC cell lines harboring the KRAS mutation, namely G12A, G12C, G12V and G13D, with one wild type cell line as the control; SW1463 and Caco-2 cell lines were used for further experiments. Sulforhodamine B assays, together with the clonogenicity and invasion assay, revealed that KRAS-mutant SW1463 cells were resistant to cetuximab; however, 4-AAQB treatment effectively resensitized CRC cells to cetuximab through the reduction of colony formation, invasion, and tumorsphere generation and of oncogenic KRAS signaling cascade of CRC cells. Thus, inducing cells with 4-AAQB before cetuximab therapy could resensitize KRAS-mutant, but not wild-type, cells to cetuximab. Therefore, we hypothesized that 4-AAQB can inhibit KRAS. In silico analysis of the publicly available GEO (GSE66548) dataset of KRAS-mutated versus KRAS wild-type CRC patients confirmed that miR-193a-3p was significantly downregulated in the former compared with the latter patient population. Overexpression of miR-193a-3p considerably reduced the oncogenicity of both CRC cells. Furthermore, KRAS is a key target of miR-193a-3p. In vivo treatment with the combination of 4-AAQB and cetuximab significantly reduced the tumor burden of a xenograft mice model through the reduction of the expression of oncogenic markers (EGFR) and p-MEK, p-ERK, and c-RAF/p-c-RAF signaling, with the simultaneous induction of miR-193a-3p expression in the plasma. In summary, our findings provide strong evidence regarding the therapeutic effect of 4-AAQB on KRAS-mutant CRC cells. Furthermore, 4-AAQB effectively inhibits Ras singling in CRC cells, through which KRAS-mutant CRC can be resensitized to cetuximab.", "claims": [{"id": "claim-method", "statement": "Kaplan–Meier (K-M) survival curves were generated using online cBioPortal tools for TCGA data.", "kind": "methodological", "target": null, "evidence": [{"asset": "source:pmid:34299137", "locator": "sections[23] \"4.13. Statistical Analysis\" paragraph 2", "quote": "Kaplan–Meier (K-M) survival curves were generated using online cBioPortal tools for TCGA data."}], "state": "complete"}, {"id": "claim-data-access", "statement": "The datasets used and analyzed in the current study are publicly accessible, as indicated in the manuscript.", "kind": "methodological", "target": null, "evidence": [{"asset": "source:pmid:34299137", "locator": "sections[32] \"Data Availability Statement\" paragraph 2", "quote": "The datasets used and analyzed in the current study are publicly accessible, as indicated in the manuscript."}], "state": "complete"}], "gaps": []}, "experiment": {"state": "complete", "objective": null, "steps": [{"id": "read_published_estimate", "order": 1, "name": "Read the published estimate from the source", "kind": "other", "state": "complete", "blocked_on": null, "description": "The claim, method and evidence span published with the source article.", "duration_hours": null, "parameters": {}, "inputs": ["source:pmid:34299137"], "outputs": ["the published estimate and its evidence"], "instruments": [], "reagents": []}, {"id": "obtain_source_data", "order": 2, "name": "Obtain the source data from the named repository", "kind": "data-preparation", "state": "complete", "blocked_on": null, "description": "The GEO series accession resolves and its sample accessions are listed. This lane did not download the dataset or read its licence.", "duration_hours": null, "parameters": {}, "inputs": ["data:geo:GSE66548"], "outputs": ["the source data with its repository provenance"], "instruments": [], "reagents": []}, {"id": "run_analysis", "order": 3, "name": "Run the published analysis", "kind": "analysis", "state": "complete", "blocked_on": null, "description": "Apply the paper's statistical method to the resolved series and compare the result with the published target.", "duration_hours": null, "parameters": {}, "inputs": ["data:geo:GSE66548"], "outputs": ["the replicated result and its comparison"], "instruments": [], "reagents": []}], "materials": [], "instruments": [], "reagents": [], "conditions": {}, "gaps": []}, "data": {"state": "partial", "assets": [{"id": "source:pmid:34299137", "role": "manuscript", "format": "xml", "media_type": "application/xml", "uri": "https://doi.org/10.3390/ijms22147508", "sha256": "sha256:91950514bc7a06a0312623778c5f5c52a263b8422520c7a66614cb4c8bafc715", "bytes": 55661, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "10.3390/ijms22147508", "version": null, "note": "Full article fetched from PMC; the checksum covers the rendered section body, not the original XML bytes.", "structure": {"pmcid": "PMC8307961", "source": "europe_pmc_fulltext", "coverage": "whole_body", "text_hash_scope": "rendered_section_body"}}, {"id": "data:geo:GSE66548", "role": "raw", "format": "geo-series", "media_type": "application/vnd.ncbi.geo-series+json", "uri": "https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE66548", "sha256": null, "bytes": null, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "GSE66548", "version": null, "note": "The datasets used and analyzed in the current study are publicly accessible, as indicated in the manuscript.", "structure": {"repository": "GEO", "access_route": "GEO accession URL", "access_statement_verbatim": "The datasets used and analyzed in the current study are publicly accessible, as indicated in the manuscript.", "access_statement_kind": "data_availability_statement", "sample_accessions": ["GSM1624756", "GSM1624757", "GSM1624758", "GSM1624759", "GSM1624760", "GSM1624761", "GSM1624762", "GSM1624763", "GSM1624764", "GSM1624765", "GSM1624766", "GSM1624767", "GSM1624768", "GSM1624769", "GSM1624770", "GSM1624771", "GSM1624772", "GSM1624773", "GSM1624774", "GSM1624775", "GSM1624776", "GSM1624777", "GSM1624778", "GSM1624779", "GSM1624780", "GSM1624781", "GSM1624782", "GSM1624783", "GSM1624784", "GSM1624785"], "sample_count": 30, "group_sizes": null, "group_sizes_basis": null, "platform": "16770", "taxon": "Homo sapiens", "title": "microRNA expression profile between KRAS/BRAF wild and BRAF mutant colorectal cancer", "resolution_checked_at": "2026-11-01T15:39:55Z", "resolution_check": "identifier_resolution_only_no_download_no_licence_read", "downloaded": false, "licence_read": false}}], "gaps": ["asset:data:geo:GSE66548 not downloaded", "asset:data:geo:GSE66548 licence not read"]}, "analysis": {"state": "partial", "methods": [{"id": "method-1", "family": null, "specific": null, "label": "Kaplan–Meier survival analysis", "dsl_operations": [], "missing_operations": [], "expressible": null, "parameters": {}, "data_shapes": [], "evidence": {"score": 1.0, "band": "verbatim", "quote": "Kaplan–Meier (K-M) survival curves were generated using online cBioPortal tools for TCGA data."}}], "targets": [], "gaps": ["method.reader_named_unmapped"]}, "capability": {"state": "complete", "requirements": [{"capability_id": "capability:computational_analysis", "label": "Computational analysis platform", "assay_families": ["meta_analysis", "machine_learning", "survival_analysis", "statistical_regression", "pca", "molecular_docking", "network_analysis", "differential_expression", "gwas"], "availability_state": "owned", "tier_unlocked": "R1", "candidate": "Automated Assays Laravel application and simulated adapters"}], "gaps": []}, "readiness": {"state": "blocked", "tier": "R4", "blocking_axis": "method", "blocked_on": "method:not_determinable", "axes": {"method": {"tier": "R4", "expressible": false, "required_operations": [], "missing_operations": [], "basis": "The reader quoted the method the paper names (Kaplan–Meier survival analysis), but the corpus's method extractor could not map it onto a DSL operation, so the method is published but not expressible."}, "capability": {"tier": "R1", "capability_id": "capability:computational_analysis", "availability_state": "owned", "basis": "The computational analysis is owned. The physical bench the paper used is not, so a physical validation cannot be run here."}, "data": {"tier": "R1", "reachable": true, "accessions": ["GSE66548"], "resolved_accessions": ["GSE66548"], "statements": ["The datasets used and analyzed in the current study are publicly accessible, as indicated in the manuscript."], "basis": "The paper names GSE66548 in Gene Expression Omnibus (GEO) and the accession resolves in the repository. No dataset was downloaded and no licence was read."}}, "can_run": {"dsl_operations": [], "assets": ["source:pmid:34299137", "data:geo:GSE66548"], "steps": ["run_analysis"]}, "must_build": {"dsl_operations": [], "converters": [], "readers": [], "capabilities": [], "data_gaps": ["data:geo:GSE66548"]}, "gaps": ["method:not_determinable"]}, "review": {"state": "partial", "machine_critique": {"kind": "extraction_review", "reader": {"model": "MiniMax-M3.1-Flash", "provider": "minimax", "provider_family": "minimax", "read_at": "2026-10-31T18:32:49Z", "independence": "single_reader"}, "evidence_check": {"method": "verbatim", "availability": "verbatim"}, "calls": 3, "usage": {"prompt_tokens": 47622, "completion_tokens": 2049, "cached_tokens": 784}}, "human_critique": null, "stages": [{"id": "extraction", "state": "complete", "reader": "MiniMax-M3.1-Flash", "provider": "minimax"}], "gaps": ["review.independent_reader", "review.machine_critique", "review.human_critique"]}, "execution": {"state": "absent", "status": "not_run", "mode": null, "runs": [], "gaps": ["execution.not_run"]}, "provenance": {"entities": [{"id": "pmid:34299137", "type": "paper", "label": "pmid:34299137"}, {"id": "source:pmid:34299137", "type": "manuscript", "label": "PMID 34299137 full text"}, {"id": "data:geo:GSE66548", "type": "dataset", "label": "GEO GSE66548"}], "activities": [{"id": "activity-reading-sci-2026-11-01", "type": "classification", "used": [{"id": "pmid:34299137", "type": "paper", "label": "pmid:34299137"}, {"id": "source:pmid:34299137", "type": "manuscript", "label": "PMID 34299137 full text"}, {"id": "data:geo:GSE66548", "type": "dataset", "label": "GEO GSE66548"}], "agent": "agent:corpus-assay-engine"}, {"id": "activity-read-34299137", "type": "extraction", "used": ["source:pmid:34299137"], "agent": "agent:minimax-reader"}, {"id": "activity-resolve-GSE66548", "type": "accession_resolution", "used": ["data:geo:GSE66548"], "agent": "agent:corpus-assay-engine"}], "agents": [{"id": "agent:corpus-assay-engine", "type": "software", "label": "Corpus assay engine"}, {"id": "agent:minimax-reader", "type": "software", "label": "MiniMax literature reader"}], "source_run_id": "reading-sci-2026-11-01", "dsl_catalogue_fingerprint": "343fb30756ba6ec3", "capability_table_fingerprint": "2cb3e42f047d2ecf", "snapshot_id": "ba34b49490d9bfaf"}, "lineage": {"parent_id": "pmid:34299137", "parent_hash": "sha256:00df6b26c0ab56c2ede5d1f88b2f105dc0f1e1a7355527daef20571c0e9ba565", "fork_of": null, "generation": 2}, "gaps": ["asset:data:geo:GSE66548 licence not read", "asset:data:geo:GSE66548 not downloaded", "execution.not_run", "method.reader_named_unmapped", "review.human_critique", "review.independent_reader", "review.machine_critique"], "assays": [{"role": "data_generation", "definition_id": "animal_model", "definition_version": "99e1195c7d6f", "definition_digest": null, "required_operations": [], "support_state": "partial", "source_hashes": {"assay_lexicon": "99e1195c7d6f"}, "confidence": 0.77, "evidence": ["ermore, KRAS is a key target of miR-193a-3p. In vivo treatment with the combination of 4-AAQB and"], "order_basis": "paper_text_order:1816", "id": "assay:1"}]}